Search results (281)
« Back to PublicationsTTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.
Journal article
Prunotto G. et al, (2026), J Hum Immun, 2
Neutralising autoantibodies against IL-10 and HLA-DRB1*01:03 in paediatric patients with inflammatory bowel disease.
Journal article
Gharahdaghi N. et al, (2026), Gut
Targeting SYK to alleviate MDSC-driven immunosuppression and augment anti-PD1 efficacy.
Journal article
Zeng Z. et al, (2026), Sci China Life Sci
HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association study.
Journal article
Zhang Q. et al, (2026), Lancet Gastroenterol Hepatol
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.
Journal article
Gharahdaghi N. et al, (2026), N Engl J Med, 394, 2212 - 2222
P222 Defining the cellular basis of acute severe ulcerative colitis
Conference paper
Pakpoor J. et al, (2026), a220.2 - a2a221
Resolving inflammatory bowel disease risk variants to genes and cell types
Preprint
Fachal L. et al, (2026)
Exome sequencing directly implicates 68 genes in inflammatory bowel disease
Preprint
Zhu R. et al, (2026)
Divergent effects of HLA-DQA1:p.Gln198Glu on trajectory in inflammatory bowel disease
Preprint
Fachal L. et al, (2026)
102 DISEASE COURSE OF CROHN’S DISEASE AFTER ILEOCECAL RESECTION IN THE ERA OF BIOLOGICS: A BINATIONAL POPULATION-BASED COHORT STUDY
Journal article
Vestergaard MV. et al, (2026), Gastrointestinal Endoscopy, 103, s - 867
102 DISEASE COURSE OF CROHN’S DISEASE AFTER ILEOCECAL RESECTION IN THE ERA OF BIOLOGICS: A BINATIONAL POPULATION-BASED COHORT STUDY
Journal article
Vestergaard MV. et al, (2026), Gastroenterology, 170, s - 867
Tu1437 DEFINING THE CELLULAR BASIS OF ACUTE SEVERE ULCERATIVE COLITIS
Journal article
Pakpoor J. et al, (2026), Gastroenterology, 170
Tu1437 DEFINING THE CELLULAR BASIS OF ACUTE SEVERE ULCERATIVE COLITIS
Conference paper
Pakpoor J. et al, (2026), Gastrointestinal Endoscopy, 103
OS-065 Evidence for bile acid-mediated ileal barrier function deficits in primary sclerosing cholangitis
Conference paper
Ilott N. et al, (2026), Journal of Hepatology, 84
Sa1490 MIRIKIZUMAB INDUCTION RESPONSE IS ASSOCIATED WITH MOLECULAR- AND CELLULAR-BASED TISSUE ARCHETYPE FEATURES OF MUCOSAL RECOVERY IN ULCERATIVE COLITIS
Journal article
Fernandes NJ. et al, (2026), Gastroenterology, 170, s - 951